Original Publication Date: 1 January, 2015
Publication / Source: Future Oncology
Authors: Ishwaria Mohan Subbiah & Vivek Subbiah
The individual and societal impact of cancer remains a problem of Herculean proportions and one that is expected to outpace cardiovascular disease as the primary killer of humans in developed nations. With such a rise in incidence comes the need for the rapid development of novel therapies. The advent of next-generation sequencing technologies has led to a rapid expansion of the molecular profiling of patients with cancer.